van Eijk, Ruben P. A.
Eijkemans, Marinus J. C.
Nikolakopoulos, Stavros
Jansen, Marc D.
Westeneng, Henk-Jan
van Eijk, Kristel R.
van der Spek, Rick A. A.
van Vugt, Joke J. F. A.
Piepers, Sanne
Groeneveld, Geert-Jan
Veldink, Jan H.
van den Berg, Leonard H.
van Es, Michael A.
Article History
Received: 21 February 2019
Revised: 10 September 2019
Accepted: 3 October 2019
First Online: 17 October 2019
Compliance with ethical standards
:
: RPAvE, SN, MDJ, H-JW, KRvE, RAAvdS, JJFAvV, SP, G-JG, JHV, MJCE report no disclosures. MAvE received grants from the Netherlands Organization for Health Research and Development (Veni scheme), The Thierry Latran foundation and the Netherlands ALS foundation (Stichting ALS Nederland), the EU Joint Programme—Neurodegenerative Disease Research (JPND). LHvdB reports grants from Netherlands ALS Foundation, the Netherlands Organization for Health Research and Development (Vici scheme), the Netherlands Organization for Health Research and Development (SOPHIA, STRENGTH, ALS-CarE project), funded through the EU Joint Programme—Neurodegenerative Disease Research, JPND), served on the Scientific Advisory Board of Biogen, Cytokinetics, Prinses Beatrix SpierFonds, and the Latran Foundation.